Business Leaders

Age : 68

Public asset : 223,767 USD

Linked companies :

Shanghai RAAS Blood Products Co., Ltd. -

Grifols, S.A. -

Biotest AG

Summary

David Ian Bell is Chief Development Officer & General Counsel at Grifols SA and on the board of 8 other companies.

Dr. Bell previously held the position of Partner at Knapp, Petersen & Clarke PC, Vice President-Operations & Development at Grifols, Inc., Member of California State Bar Association and Vice President & General Counsel of Alpha Therapeutic Corp.

David Ian Bell received a graduate degree from Harvard Law School, a graduate degree from Southwestern Law School and an undergraduate degree from the University of California, Irvine.

Current positions of David Ian Bell

Name	Title	Since
Shanghai RAAS Blood Products Co., Ltd. (Pharmaceuticals)	Director	2020
Biotest AG (Pharmaceuticals)	Member-Supervisory Board	2022
Grifols, S.A. (Pharmaceuticals)	Chief Development Officer & General Counsel	2021
Grifols Innovation & New Technologies Ltd.	President & Chief Executive Officer	-
Biomat USA, Inc.	Chairman & General Counsel	-
Singulex, Inc.	Director	-
Alkahest, Inc.	Director	-
Plasma Protein Therapeutics Association	Director	2020
Grifols USA, Inc.	Vice President-Corporate Operations & Development	2013
BPC Plasma, Inc.	Director	-
VCN Biosciences SL	Director	-
GigaGen, Inc.	Director	-

Holdings of David Ian Bell

Name	Equities	%	Valuation
Grifols, S.A. (GRF) (Pharmaceuticals)	20,000	0.0047%	223,767 USD

David Ian Bell: Personal Network

Name	Linked companies
Tomás Dagá Gelabert	Grifols, S.A. Shanghai RAAS Blood Products Co., Ltd. Biotest AG Grifols USA, Inc. Grifols Innovation & New Technologies Ltd. Biomat USA, Inc. BPC Plasma, Inc. Alkahest, Inc.
Raimon Grifols Roura	Grifols, S.A. Biotest AG Grifols USA, Inc. VCN Biosciences SL
Alfredo Arroyo Guerra	Grifols, S.A. Grifols USA, Inc.
Víctor Grifols Roura	Grifols, S.A. Grifols USA, Inc.
Lafmin Morgan	Grifols, S.A. Grifols USA, Inc.
Joel E. Abelson	Grifols USA, Inc.
George Oliver	Grifols USA, Inc.
Thomas Heinrich Glanzmann	Grifols, S.A. Plasma Protein Therapeutics Association Alkahest, Inc.
Vicente Blanquer Torre	Grifols, S.A.
Enrico D'Aiuto	Biotest AG